Clinical Trial

A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients

Name: A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients — clinical trial record (NCT06537752)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate ethanol-induced symptoms and safety in breast cancer patients with neoadjuvant/adjuvant chemotherapy including Non-ethanol formulation docetaxel before and after surgery

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-07-31.

Trial Details

NCT Number	NCT06537752
Lead Sponsor	Boryung Pharmaceutical Co., Ltd
Conditions	Breast Cancer
Enrollment	1,052 participants
Start Date	2024-07-15
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2025-09-12